deanol has been researched along with Dyskinesia Syndromes in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 23 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Casey, DE | 4 |
Heisler, S; Widroe, HJ | 1 |
Fortemps, E; Laterre, EC | 1 |
Carroll, BJ; Nesse, R | 1 |
Osvaldo, NR | 1 |
Kanapa, DJ; Klawans, HL; Weiner, WJ | 1 |
Escobar, JI; Kemp, KF | 1 |
Curran, DJ; Mohan, KJ; Nagaswami, S | 1 |
Casey, DE; Denny, D | 1 |
De Silva, L; Huang, CY | 1 |
Fann, WE; McKenzie, GM; Miller, RD; Sullivan, JL | 1 |
Bergen, D; Klawans, HL; Topel, JL | 1 |
Clyne, KE; Juhl, R | 1 |
Re', O | 1 |
Miller, EM | 1 |
Casey, DE; Denney, D | 1 |
Tarsy, D | 1 |
Miller, E | 1 |
Fowler, GW; Millichap, JG | 1 |
3 review(s) available for deanol and Dyskinesia Syndromes
Article | Year |
---|---|
Deanol in the management of involuntary movement disorders: a review.
Topics: Acetylcholine; Deanol; Dopamine; Dyskinesia, Drug-Induced; Ethanolamines; Female; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Models, Neurological; Movement Disorders; Parkinson Disease; Physostigmine; Research Design; Time Factors | 1977 |
2-Dimethylaminoethanol (deanol): a brief review of its clinical efficacy and postulated mechanism of action.
Topics: Acetylcholine; Blood-Brain Barrier; Brain Chemistry; Carbon Radioisotopes; Child; Choline; Deanol; Dihydroxyphenylalanine; Ethanolamines; Humans; Huntington Disease; Hyperkinesis; Learning Disabilities; Movement Disorders; Parkinson Disease; Time Factors | 1974 |
Treatment of "minimal brain dysfunction" syndromes. Selection of drugs for children with hyperactivity and learning disabilities.
Topics: Amphetamine; Anticonvulsants; Brain Damage, Chronic; Child; Chlordiazepoxide; Chlorpromazine; Clinical Trials as Topic; Deanol; Humans; Learning Disabilities; Methylphenidate; Movement Disorders; Placebos; Reserpine; Tranquilizing Agents | 1967 |
2 trial(s) available for deanol and Dyskinesia Syndromes
Article | Year |
---|---|
Mood alterations during deanol therapy.
Topics: Affective Symptoms; Alcoholism; Clinical Trials as Topic; Deanol; Double-Blind Method; Dyskinesia, Drug-Induced; Emotions; Ethanolamines; Humans; Movement Disorders; Placebos | 1979 |
Treatment of "minimal brain dysfunction" syndromes. Selection of drugs for children with hyperactivity and learning disabilities.
Topics: Amphetamine; Anticonvulsants; Brain Damage, Chronic; Child; Chlordiazepoxide; Chlorpromazine; Clinical Trials as Topic; Deanol; Humans; Learning Disabilities; Methylphenidate; Movement Disorders; Placebos; Reserpine; Tranquilizing Agents | 1967 |
19 other study(ies) available for deanol and Dyskinesia Syndromes
Article | Year |
---|---|
Pharmacology of blepharospasm-oromandibular dystonia syndrome.
Topics: Aged; Benztropine; Blepharospasm; Carbidopa; Deanol; Drug Therapy, Combination; Electromyography; Eyelid Diseases; Humans; Jaw Diseases; Levodopa; Male; Middle Aged; Movement Disorders; Syndrome | 1980 |
Treatment of tardive dyskinesia.
Topics: Adult; Aged; Antipsychotic Agents; Deanol; Female; Humans; Movement Disorders; Phenothiazines | 1976 |
Letter: Deanol in spontaneous and induced dyskinesias.
Topics: Deanol; Drug Evaluation; Ethanolamines; Humans; Movement Disorders | 1975 |
Letter: Cholinergic side-effects associated with deanol.
Topics: Adult; Deanol; Ethanolamines; Female; Humans; Movement Disorders; Parasympathetic Nervous System | 1976 |
Deanol in L-dopa and tardive dyskinesias: a review.
Topics: Deanol; Ethanolamines; Humans; Levodopa; Movement Disorders; Phenothiazines | 1975 |
The effect of dimethylaminoethanol (deanol) on amphetamine-induced stereotyped behavior (AISB).
Topics: Acetylcholine; Animals; Behavior; Deanol; Dextroamphetamine; Ethanolamines; Guinea Pigs; Humans; Male; Movement Disorders; Stereotyped Behavior | 1976 |
Letter: Dimethylaminoethanol for tardive dyskinesia.
Topics: Aged; Deanol; Drug Evaluation; Ethanolamines; Female; Humans; Male; Middle Aged; Movement Disorders | 1975 |
Treatment of phenothiazine induced bulbar persistent dyskinesia with deanol acetamidobenzoate.
Topics: Acetamides; Adult; Benzoates; Chlorpromazine; Deanol; Ethanolamines; Humans; Male; Movement Disorders; Trifluoperazine | 1975 |
Letter: Deanol for tardive dyskinesia.
Topics: Adult; Aged; Deanol; Ethanolamines; Female; Humans; Male; Middle Aged; Movement Disorders | 1975 |
Deanol in the treatment of tardive dyskinesia.
Topics: Chlorpromazine; Deanol; Ethanolamines; Humans; Male; Middle Aged; Movement Disorders; Trifluoperazine | 1975 |
Letter: Deanol for tardive dyskinesia.
Topics: Deanol; Drug Evaluation; Ethanolamines; Humans; Movement Disorders | 1975 |
Deanol in tardive dyskinesia.
Topics: Adult; Aged; Deanol; Ethanolamines; Female; Humans; Male; Middle Aged; Movement Disorders; Tranquilizing Agents | 1975 |
Deanol in tardive dyskinesia: a preliminary report.
Topics: Deanol; Ethanolamines; Humans; Movement Disorders | 1975 |
Deanol in the treatment of levodopa-induced dyskinesias.
Topics: Aged; Deanol; Drug Evaluation; Ethanolamines; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease | 1975 |
Tardive dyskinesia.
Topics: Choline; Deanol; Dopamine Antagonists; Haloperidol; Humans; Methyldopa; Movement Disorders; Papaverine; Parasympathomimetics; Reserpine; Tetrabenazine | 1976 |
Letter: Deanol: a solution for tardive dyskinesia?
Topics: Aged; Chlorpromazine; Deanol; Ethanolamines; Female; Humans; Male; Middle Aged; Movement Disorders; Trifluoperazine | 1974 |
Letter: Dimethylaminoethanol in tardive dyskinesia.
Topics: Chlorpromazine; Deanol; Ethanolamines; Humans; Male; Middle Aged; Movement Disorders; Trifluoperazine | 1974 |
Letter: Deanol in tardive dyskinesia.
Topics: Animals; Brain; Deanol; Ethanolamines; Humans; Movement Disorders; Tranquilizing Agents | 1974 |
Deanol in the treatment of levodopa-induced dyskinesias.
Topics: Aged; Antidepressive Agents; Deanol; Dihydroxyphenylalanine; Ethanolamines; Female; Humans; Male; Mastication; Middle Aged; Movement Disorders; Parkinson Disease | 1974 |